FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ellen Burgess

Research Profile

Disorders

Chemicals & Drugs

Geographic Areas

Canada

Procedures

Occupations

Evidence-Based Medicine

Concepts & Ideas

Co-author Network

Publications

TOP 3
J Steven A Simpson; Susan G Crawford; Estelle T Goldstein; Catherine Field; Ellen Burgess; Bonnie J Kaplan
Systematic review of safety and tolerability of a complex micronutrient formula used in mental health.
Ellen Burgess
Reviewing the benefits of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in diabetic nephropathy--are they drug specific or class specific?
Ellen Burgess; Norman Muirhead; Paul Rene de Cotret; Anthony Chiu; Vincent Pichette; Sheldon Tobe
Supramaximal dose of candesartan in proteinuric renal disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ellen Burgess (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: J Steven A Simpson; Susan G Crawford; Estelle T Goldstein; Catherine Field; Ellen Burgess; Bonnie J Kaplan
Systematic review of safety and tolerability of a complex micronutrient formula used in mental health.
BMC psychiatry 2011;11():62.
2010: Ellen Burgess
Reviewing the benefits of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in diabetic nephropathy--are they drug specific or class specific?
The Canadian journal of cardiology 2010;26 Suppl E():15E-19E.
2009: Ellen Burgess; Norman Muirhead; Paul Rene de Cotret; Anthony Chiu; Vincent Pichette; Sheldon Tobe
Supramaximal dose of candesartan in proteinuric renal disease.
Journal of the American Society of Nephrology : JASN 2009;20(4):893-900.
2008: Ellen Burgess
Slowing the progression of kidney disease in patients with diabetes.
Journal of the American Society of Hypertension : JASH 2008;2(4 Suppl):S30-7.
2008: Raj J Padwal; Brenda R Hemmelgarn; Nadia A Khan; Steven Grover; Finlay A McAlister; Donald W McKay; Thomas Wilson; Brian Penner; Ellen Burgess; Peter Bolli; Michael D Hill; Jeffrey L Mahon; Martin G Myers; Carl Abbott; Ernesto L Schiffrin; George Honos; Karen Mann; Guy Tremblay; Alain Milot; Lyne Cloutier; Arun Chockalingam; Simon W Rabkin; Martin Dawes Dawes; Rhian M Touyz; Chaim Bell; Kevin D Burns; Marcel Ruzicka; Norman R C Campbell; Marcel Lebel; Sheldon W Tobe
The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 - blood pressure measurement, diagnosis and assessment of risk.
The Canadian journal of cardiology 2008;24(6):455-63.
2007: Raj Padwal; Brenda R Hemmelgarn; Finlay A McAlister; Donald W McKay; Steven Grover; Thomas Wilson; Brian Penner; Ellen Burgess; Peter Bolli; Michael Hill; Jeffrey L Mahon; Martin G Myers; Carl Abbott; Ernest L Schiffrin; George Honos; Karen Mann; Guy Tremblay; Alain Milot; Lyne Cloutier; Arun Chockalingam; Nadia A Khan; Simon W Rabkin; Martin Dawes; Rhian M Touyz; Sheldon W Tobe
The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk.
The Canadian journal of cardiology 2007;23(7):529-38.
2006: Sheldon W Tobe; Ellen Burgess; Marcel Lebel
Atherosclerotic renovascular disease.
The Canadian journal of cardiology 2006;22(7):623-8.
2006: Brenda R Hemmelgarn; Finlay A McAlister; Steven Grover; Martin G Myers; Donald W McKay; Peter Bolli; Carl Abbott; Ernesto L Schiffrin; George Honos; Ellen Burgess; Karen Mann; Thomas Wilson; Brian Penner; Guy Tremblay; Alain Milot; Arun Chockalingam; Rhian M Touyz; Sheldon W Tobe
The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.
The Canadian journal of cardiology 2006;22(7):573-81.
2004: Ellen Burgess
Eplerenone in hypertension.
Expert opinion on pharmacotherapy 2004;5(12):2573-81.
2004: Nalini Singhal; Kathleen Oberle; Amy Darwish; Ellen Burgess
Attitudes of health-care providers towards research with newborn babies.
Journal of perinatology : official journal of the California Perinatal Association 2004;24(12):775-82.
2004: Ellen Burgess; George W Carides; William C Gerth; Michael A Marentette; Isabelle Chabot
Losartan reduces the costs associated with nephropathy and end-stage renal disease from type 2 diabetes: Economic evaluation of the RENAAL study from a Canadian perspective.
The Canadian journal of cardiology 2004;20(6):613-8.
2004: Gordon H Williams; Ellen Burgess; Rainer E Kolloch; Luis M Ruilope; Joanna Niegowska; Mark S Kipnes; Barbara Roniker; Jeffrey L Patrick; Scott L Krause
Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension.
The American journal of cardiology 2004;93(8):990-6.
2003: Ellen Burgess; Yves Lacourcière; Luis M Ruilope-Urioste; Suzanne Oparil; Jay H Kleiman; Scott Krause; Barbara Roniker; Clement Maurath
Long-term safety and efficacy of the selective aldosterone blocker eplerenone in patients with essential hypertension.
Clinical therapeutics 2003;25(9):2388-404.
2003: Christopher J Doig; Ellen Burgess
Brain death: resolving inconsistencies in the ethical declaration of death.
Canadian journal of anaesthesia = Journal canadien d'anesthésie 2003;50(7):725-31.
2003: Ellen Burgess; Nalini Singhal; Harish J Amin; Douglas D McMillan; H Devrome
Consent for clinical research in the neonatal intensive care unit: a retrospective survey and a prospective study.
Archives of disease in childhood. Fetal and neonatal edition 2003;88(4):F280-5; discussion F285-6.
2002: Jacques LeLorier; Claire Bombardier; Ellen Burgess; Louise Moist; Noel Wright; Pierre Cartier; Victor Huckell; Richard Hunt; Tewfik Nawar; Sheldon Tobe
Practical considerations for the use of nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors in hypertension and kidney disease.
The Canadian journal of cardiology 2002;18(12):1301-8.
2002: Finlay A McAlister; Kelly B Zarnke; Norman R C Campbell; Ross D Feldman; Mitchell Levine; Jeffrey L Mahon; Steven A Grover; Richard Z Lewanczuk; Frans Leenen; Sheldon Tobe; Marcel Lebel; James Stone; Ernesto L Schiffrin; Simon W Rabkin; Richard I Ogilvie; Pierre Larochelle; Charlotte Jones; George Honos; George Fodor; Ellen Burgess; Pavel Hamet; Robert Herman; Jane Irvine; Bruce Culleton; James M Wright
The 2001 Canadian recommendations for the management of hypertension: Part two--Therapy.
The Canadian journal of cardiology 2002;18(6):625-41.
2002: Kelly B Zarnke; Finlay A McAlister; Norman R C Campbell; Mitchell Levine; Ernesto L Schiffrin; Steven Grover; Donald W McKay; Martin G Myers; Thomas W Wilson; Simon W Rabkin; Ross D Feldman; Ellen Burgess; Peter Bolli; George Honos; Marcel Lebel; Karen Mann; Carl Abbott; Sheldon Tobe; Robert Petrella; Rhian M Touyz
The 2001 Canadian recommendations for the management of hypertension: Part one--Assessment for diagnosis, cardiovascular risk, causes and lifestyle modification.
The Canadian journal of cardiology 2002;18(6):604-24.
2002: Nalini Singhal; Kathleen Oberle; Ellen Burgess; Joelene Huber-Okrainec
Parents' perceptions of research with newborns.
Journal of perinatology : official journal of the California Perinatal Association 2002;22(1):57-63.
2001: Kelly B Zarnke; Mitchell Levine; Finlay A McAlister; Norman R C Campbell; Martin G Myers; Donald W McKay; Peter Bolli; George Honos; Marcel Lebel; Karen Mann; Thomas W Wilson; Carl Abbott; Sheldon Tobe; Ellen Burgess; Simon Rabkin
The 2000 Canadian recommendations for the management of hypertension: part two--diagnosis and assessment of people with high blood pressure.
The Canadian journal of cardiology 2001;17(12):1249-63.
2001: Norman R C Campbell; L Milkovich; Ellen Burgess; Donald W McKay
Self-measurement of blood pressure: accuracy, patient preparation for readings, technique and equipment.
Blood pressure monitoring 2001;6(3):133-8.
2001: Finlay A McAlister; Mitchell Levine; Kelly B Zarnke; Norman Campbell; Richard Z Lewanczuk; Frans Leenen; Simon Rabkin; J M Wright; J Stone; Ross D Feldman; Marcel Lebel; George Honos; George Fodor; Ellen Burgess; Sheldon Tobe; Pavel Hamet; R Herman; J Irvine; Bruce Culleton; R Petrella; Rhian M Touyz
The 2000 Canadian recommendations for the management of hypertension: Part one--therapy.
The Canadian journal of cardiology 2001;17(5):543-59.
2000: Kathleen Oberle; Nalini Singhal; J Huber; Ellen Burgess
Development of an instrument to investigate parents' perceptions of research with newborn babies.
Nursing ethics 2000;7(4):327-38.
2000: Christopher J Doig; Ellen Burgess
Withholding life-sustaining treatment: are adolescents competent to make these decisions?
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2000;162(11):1585-8.
2000: Margaret L Russell; D G Moralejo; Ellen Burgess
Paying research subjects: participants' perspectives.
Journal of medical ethics 2000;26(2):126-30.
1999: Ellen Burgess
Management of focal segmental glomerulosclerosis: evidence-based recommendations.
Kidney international. Supplement 1999;70():S26-32.
1999: Ellen Burgess
Conservative treatment to slow deterioration of renal function: evidence-based recommendations.
Kidney international. Supplement 1999;70():S17-25.
1999: Ellen Burgess; Richard Z Lewanczuk; Peter Bolli; A Chockalingam; H Cutler; G Taylor; P Hamet
Lifestyle modifications to prevent and control hypertension. 6. Recommendations on potassium, magnesium and calcium. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1999;160(9 Suppl):S35-45.
1999: Norman R C Campbell; Ellen Burgess; B C Choi; G Taylor; E Wilson; J Cléroux; J George Fodor; L A Leiter; D Spence
Lifestyle modifications to prevent and control hypertension. 1. Methods and an overview of the Canadian recommendations. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1999;160(9 Suppl):S1-6.
1999: Norman R C Campbell; Ellen Burgess; G Taylor; E Wilson; J Cléroux; J George Fodor; L Leiter; J D Spence
Lifestyle changes to prevent and control hypertension: do they work? A summary of the Canadian consensus conference.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1999;160(9):1341-3.
1999: Ross D Feldman; Norman Campbell; Pierre Larochelle; Peter Bolli; Ellen Burgess; SG Carruthers; J S Floras; R Brian Haynes; George Honos; Frans Leenen; L A Leiter; A G Logan; Martin G Myers; J David Spence; Kelly B Zarnke
1999 Canadian recommendations for the management of hypertension. Task Force for the Development of the 1999 Canadian Recommendations for the Management of Hypertension.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1999;161 Suppl 12():S1-17.
1995: Ellen Burgess; P Sargious
Charcoal hemoperfusion for theophylline overdose: case report and proposal for predicting treatment time.
Pharmacotherapy 1995;15(5):621-4.
1995: Norman R C Campbell; A Skerjanec; Y Tam; S Robertson; Ellen Burgess
Methyldopa kinetics before and after ingestion of methyldopa for eight weeks.
European journal of clinical pharmacology 1995;48(5):397-400.
1993: F Sutherland; Ellen Burgess; J Klassen; S Buckle; Leendert C Paul
Post-transplant conversion from cyclosporin to azathioprine: effect on cardiovascular risk profile.
Transplant international : official journal of the European Society for Organ Transplantation 1993;6(3):129-32.
1992: Leendert C Paul; F Sutherland; J Klassen; S Buckle; Ellen Burgess
Cardiovascular risk impact of cyclosporine immunosuppression in renal transplant recipients.
Transplantation proceedings 1992;24(6):2740-1.
1992: Ellen Burgess; D Muruve
Renal effects of peptic ulcer therapy.
Drug safety : an international journal of medical toxicology and drug experience 1992;7(4):282-91.
1992: Ellen Burgess; D Muruve; R Audette
Aluminum absorption and excretion following sucralfate therapy in chronic renal insufficiency.
The American journal of medicine 1992;92(5):471-5.
1992: Ellen Burgess
Prolonged hemodialysis in methanol intoxication.
Pharmacotherapy 1992;12(3):238-9.
1991: P Keane; Ellen Burgess; M Watanabe; T Wong
Plasma sodium-potassium ATPase inhibition activity in low- and normal-renin hypertension.
American journal of hypertension 1991;4(1 Pt 1):9-13.
1990: Ellen Burgess
Intraperitoneal cefoperazone treatment resulting in coagulation abnormality.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 1990;10(2):180-1.
1989: Ellen Burgess; H Duff; P Wilkes
Propafenone disposition in renal insufficiency and renal failure.
Journal of clinical pharmacology 1989;29(2):112-3.
1988: G Y Minuk; C E Bohme; Ellen Burgess; N B Hershfield; J K Kelly; Eldon A Shaffer; Lloyd R Sutherland; Guido M A Van Rosendaal
Pilot study of cyclosporin A in patients with symptomatic primary biliary cirrhosis.
Gastroenterology 1988;95(5):1356-63.